Trial Profile
A phase II trial of paricalcitol in myelodysplastic syndromes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Paricalcitol (Primary)
- Indications Leukaemia; Myelodysplastic syndromes
- Focus Therapeutic Use
- 25 Jan 2018 Status changed from active, no longer recruiting to completed.
- 16 Oct 2005 New trial record.